The molecular interpretation is that aged fibroblasts secrete a Wnt antagonist, sFRP2, which activates a multistep signaling cascade in melanoma cells, resulting in a decrease in β-catenin/MITF activity and in loss of the key redox effector APE1. This evidence concerns the gene APEX1 and melanoma.